This is a preview of subscription content, log in via an institution to check access.
Notes
The study was affiliated with, and funded by, Roche France.
Reference
Laurendeau C, et al. Costs and management of patients with hemophilia A in France: the Hemraude study European Journal of Health Economics : 19 Jul 2021. Available from: URL: https://doi.org/10.1007/s10198-021-01339-4
Rights and permissions
About this article
Cite this article
Management costs and economic burden of haemophilia A high in France. PharmacoEcon Outcomes News 883, 24 (2021). https://doi.org/10.1007/s40274-021-7895-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7895-5